echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Thromb Haemost: The incidence of hemophagocytic lymphohistiocytosis in adults and the incidence of thromboembolism and its impact on overall survival

    J Thromb Haemost: The incidence of hemophagocytic lymphohistiocytosis in adults and the incidence of thromboembolism and its impact on overall survival

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hemophagocytic lymphohistiocytosis is a rare syndrome characterized by uncontrolled immune system activation and a higher risk of death
    .


    There are few data on the incidence of bleeding and thromboembolism in patients with hemophagocytic lymphohistiocytosis


    Immune Thrombosis

    Recently, a research article was published in the Journal of Thrombosis and Haemostasis, the authoritative journal of thrombosis and coagulation diseases, which aims to determine the cumulative incidence of hemophagocytic lymphohistiocytosis in adults and thromboembolism and its impact on patient survival.
    Influence
    .

    Researchers conducted a multicenter retrospective cohort study of adults with hemophagocytic lymphohistiocytosis in Alberta, Canada (1999-2019)
    .


    The researchers calculated the cumulative incidence of bleeding and thromboembolism in the subjects, and considered the risk of competition


    Researchers identified 97 adults with hemophagocytic lymphohistiocytosis (median age 46 years)
    .


    Eleven (11%) patients developed venous thromboembolism (VTE) at a median time of 9 days after admission


    Thus, in adults with hemophagocytic lymphohistiocytosis, VTE appears to be more common than previously described and is a predictor of patient death, although this may be due to unadjusted confounding factors
    .


    Due to the high bleeding rate, the prevention and treatment of VTE is challenging


    In adults with hemophagocytic lymphohistiocytosis, VTE appears to be more common than previously described and is a predictor of patient death, although this may be due to unadjusted confounding factors


     Original Source: Incidence of Bleeding and thromboembolism and Impact ON Overall Survival in Adult patients with hemophagocytic lymphohistiocytosis: A 20-year Provincial Retrospective cohort Study in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.